ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
51.41
+0.91 (1.80%)
Dec 20, 2024, 4:00 PM EST - Market closed
BIB Holdings List
As of Dec 19, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | n/a | Cte ? Proshares Trust M | 16.17% |
2 | B 0 04.01.25 | United States Treasury Bills 0% | 15.85% |
3 | GILD | Gilead Sciences, Inc. | 8.19% |
4 | VRTX | Vertex Pharmaceuticals Incorporated | 5.69% |
5 | AMGN | Amgen Inc. | 5.56% |
6 | n/a | Cash | 4.93% |
7 | REGN | Regeneron Pharmaceuticals, Inc. | 4.25% |
8 | AZN | AstraZeneca PLC | 3.23% |
9 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.64% |
10 | BIIB | Biogen Inc. | 1.85% |
11 | ILMN | Illumina, Inc. | 1.84% |
12 | ARGX | argenx SE | 1.73% |
13 | UTHR | United Therapeutics Corporation | 1.38% |
14 | MRNA | Moderna, Inc. | 1.31% |
15 | VTRS | Viatris Inc. | 1.25% |
16 | SNY | Sanofi | 1.20% |
17 | NBIX | Neurocrine Biosciences, Inc. | 1.17% |
18 | SMMT | Summit Therapeutics Inc. | 1.15% |
19 | INCY | Incyte Corporation | 1.11% |
20 | BMRN | BioMarin Pharmaceutical Inc. | 1.07% |
21 | INSM | Insmed Incorporated | 1.03% |
22 | SRPT | Sarepta Therapeutics, Inc. | 0.98% |
23 | BNTX | BioNTech SE | 0.94% |
24 | RPRX | Royalty Pharma plc | 0.94% |
25 | MEDP | Medpace Holdings, Inc. | 0.90% |
26 | PCVX | Vaxcyte, Inc. | 0.83% |
27 | EXEL | Exelixis, Inc. | 0.83% |
28 | ITCI | Intra-Cellular Therapies, Inc. | 0.77% |
29 | ROIV | Roivant Sciences Ltd. | 0.73% |
30 | ASND | Ascendis Pharma A/S | 0.69% |
31 | BGNE | BeiGene, Ltd. | 0.66% |
32 | JAZZ | Jazz Pharmaceuticals plc | 0.65% |
33 | RVMD | Revolution Medicines, Inc. | 0.62% |
34 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.55% |
35 | HALO | Halozyme Therapeutics, Inc. | 0.52% |
36 | BPMC | Blueprint Medicines Corporation | 0.49% |
37 | CYTK | Cytokinetics, Incorporated | 0.47% |
38 | IONS | Ionis Pharmaceuticals, Inc. | 0.45% |
39 | NUVL | Nuvalent, Inc. | 0.43% |
40 | ALKS | Alkermes plc | 0.43% |
41 | BBIO | BridgeBio Pharma, Inc. | 0.42% |
42 | KRYS | Krystal Biotech, Inc. | 0.40% |
43 | AXSM | Axsome Therapeutics, Inc. | 0.37% |
44 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.36% |
45 | ADMA | ADMA Biologics, Inc. | 0.36% |
46 | ACLX | Arcellx, Inc. | 0.35% |
47 | APLS | Apellis Pharmaceuticals, Inc. | 0.35% |
48 | RARE | Ultragenyx Pharmaceutical Inc. | 0.35% |
49 | GH | Guardant Health, Inc. | 0.33% |
50 | IMVT | Immunovant, Inc. | 0.32% |
As of Dec 19, 2024